0% found this document useful (0 votes)
119 views65 pages

Hypertension Lectures

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1/ 65

HYPERTENSION

INTRODUCTION
• Defined as blood pressure persistently ≥
140/90mmHg
• Hypertension is an important public health
problem worldwide.
• Hypertension is an acknowledged potential risk
factor in the development of cardiovascular
diseases like stroke, coronary heart disease,
renal failure and congestive heart failure .
INTRODUCTION
• The prevalence of HTN increases with age
• The risk of morbidity and mortality rises with
increasing systolic and diastolic BP
• Patients with isolated systolic HTN have 2-3x
increase in risk of cardiac mortality
EPIDEMIOLOGY
• Ogah et al documented 43 studies on
prevalent rates of hypertension in Nigeria
between 1960 and 2012. The overall
prevalence of hypertension in Nigeria ranges
from 8%-46.4% depending on the study
target population
EPIDEMIOLOGY
• The estimated overall prevalence rate of
hypertension in Nigeria is 28.9% (29.5% in
men, 25% among women, 30.6% and 26.4% in
urban and rural areas respectively).
Precautions to take when measuring BP

• The patient should have rested for at lease 5


minutes
• Use appropriate cuff size
• Support the arm
• No stimulants like caffeine, alcohol, etc
• For diabetics and elderly patients, do erect
and supine to exclude orthostatic hypotension
TYPES OF HYPERTENSION
• PRIMARY (ESSENTIAL) HTN
• Accounts for 90% of cases of HTN
• Cause is unknown
• However its aetiology may be multifactorial
Genetic factors
• HTN tends to run in families
• Children of hypertensive parents are more
likely to be hypertensive too
• This may be explained by the shared
environmental influences
• However the actual genetic component is yet
to be identified
Foetal factors
• Low birth weight is associated with
subsequent high BP
• The exact explanation for this is not known

Environmental factors
• Obesity:
• Fat people are more likely to have high BP
than thin people
• However, in obese people, there is a risk of
measuring the BP with a small cuff
• This results to over estimation of the BP
• Obstructive sleep apnoea may also be a
contributing factor to HTN in obese people
Environmental factors
• Alcohol consumption:
• People who consume large amounts of alcohol
are more likely to be hypertensive ( > 14units
per week for females; > 21 units per week for
males)
• Studies have shown that subjects who drink
small quantities of alcohol are less likely to be
hypertensive compared to those who don’t take
alcohol
Environmental factors
• Sodium intake:
• Populations who take higher amount of salt have
higher blood pressures than those who consume
less sodium
• The high salt diet consumed by people who
move from rural to urban areas may be a
contributor to the high BP seen in them
• Some studies have shown that high potassium
diet may be protective.
Environmental factors
• Stress:
• Acute stress and pain can cause elevated BP
• However, the relationship between chronic
stress and HTN is uncertain
Other risk factors
• Insulin resistance:
• In metabolic syndrome-X, there is
hyperinsulinaemia, glucose intolerance,
reduced HDL cholesterol,
hypertriglyceridaemia, central obesity and
HTN
• All these are related to insulin resistance
Other risk factors
• Humoral mechanisms:
• The following are involved in short-term
physiologic regulation of BP:
• Autonomic nervous system
• RAAS
• Natriuretic peptide
SECONDARY HYPERTENSION
• RENAL DISEASE: Chronic glomerulonephritis, Adult
polycystic kidney disease (ADPKD), renal artery
stenosis, Diabetic nephropathy, etc
• COARCTATION OF THE AORTA
• ENDOCRINE DISEASES: Cushings disease, Conns
syndrome, phaeochromocytoma, acromegaly,
congenital adrenal hyperplasia, thyroid disease, etc
• DRUGS: Oral contraceptives, NSAIDS, anabolic
steroids, alcohol, monoamine oxidase inhibitors, etc
CLASSIFICATION
ESC/ESH classification (2013)
Category Systolic Diastolic
Optimal <120 and <80
Normal 120-129 and/or 80-84
High normal 130-139 and/or 85-89
Grade I 140-159 and/or 90-99
Grade 2 160-179 and/or 100-109
Grade 3 ≥ 180 and/or ≥ 110
Isolated ≥ 140 and <90
systolic HTN
JNC 7
• BP Classification
• SBPmmHg DBPmmHg
• Normal <120 <80
• Pre-hypertension 120-139 80-89
• Stage 1 140-159 90-99
• Stage 2 >160 >100
• Pre-hypertension, a new category designated
emphasizes that patients with pre-hypertension
are at risk for progression to htn and that lifestyle
modifications are important preventive strategies.
Recommendations by JNC 8
• In patients >18 years with CKD, initial or add-on therapy
should be an ACE inhibitor or ARB, regardless of race or
diabetes status
• JNC 8 recommends treating patients ages 18 to 69years who
have CKD and BP ≥140/90 mmHg.
• JNC 7’s more stringent recommendation treating such
patients with BP≥130/80 mmHg was relaxed because there:
• Is little evidence of a lower mortality rate or
cardiovascular or cerebrovascular benefits as
a result of tighter control.
• White coat hypertension: Elevated office BP,
normal out of office BP

• Masked Hypertension; patient has normal


office blood pressure and elevated out-of-
office blood pressure
PATHOPHYSIOLOGY
• The pathogenesis of essential HTN is not clear
• BP = Cardiac output (CO) x Total peripheral
resistance (TPR)
• High BP may be due to elevated CO; normal
TPR
• Elevated TPR, normal CO
• Elevated TPR and CO
Cardiac changes
• 1. Resistance in the blood vessels
• Peripheral resistance is determined by small
arterioles
• The small arterioles have smooth muscle cells
which respond to sympathetic nerve
stimulation
• Stimulation of the sympathetic nerve leads to
vasoconstriction
Cardiac changes
• In HTN, there is an increase in the muscle wall
thickness and narrowing of the lumen
diameter
• This leads to increased total peripheral
resistance and hence elevated BP with normal
cardiac output
Cardiac changes
• Changes in large vessels:
• There is thickening of the tunica media with
increased deposition of calcium and collagen
• This leads to reduced compliance of the
arterial wall and hence increased TPR
Renal changes:
• Renin also has a role in pathogenesis if HTN
• It is secreted by the juxta-glomerular
apparatus of the kidneys
• Renin is released in response to
underperfusion of the glomerulus, response
to salt intake or sympathetic stimulation
• Renin-Angiotensinogen-Angiotensin I-
Angiotensin converting enzyme-Angiotensin II
Renal changes:
• Angiotensin II is a powerful vasoconstrictor,
causes left ventricular hypertrophy.
• It also stimulates the Zona glomerulosa of the
adrenal gland to release aldosterone
• Aldosterone causes salt and water retention
• Aldosterone also causes fibrosis of the heart
muscle
• This leads to the decreased compliance of the LV
wall
Others
• Nitric Oxide: Causes vasodilatation
• Bradykinin: Vasodilator
• Endothelin: Causes vasoconstriction and may
cause salt sensitive rise in BP.
• This is usually counteracted by NO.
• However when there is an imbalance with higher
levels of endothelin and reduction in NO, there is
resultant vasoconstriction and thus elevated BP
Others
• Atrial Natruiretic peptide: Increases salt and
water excretion by in response to increased
blood volume
• Ouabain: It is a naturally occurring steroid-like
agent
• It acts on the vascular smooth muscle to cause
vasoconstriction
GENETIC FORMS OF HYPERTENSION
• LIDDLES syndrome: HTN, hypokalaemia, low
alsdosterone, low plasma renin
• GLUCOCORTICOID REMEDABLE ALDOSTERONISM
(GRA): hyperaldosteronisn, low renin, low potassium,
high sodium…(like conns syndrome)
• CONGENITAL ADRENAL HYPERPLASIA: Due to
deficiency of 11-beta-hydroxylase
• Gordon’s syndrome: xterized by hyperkalaemia,
familial HTN; due to mutation on the long arm of
chromosome 7
SYMPTOMS
• Non specific
• Headache
• Blurring of vision
• Or symptoms of complications
SIGNS
• HEART:
• Displaced , heaving apex due to LVH
• Loud A2
• S4
• KIDNEYS:
• Features of renal failure
SIGNS
• CNS:
• Transient ischaemic attack
• Stroke
• Hypertensive encephalopathy
• Subarachnoid haemorrhage
SIGNS
• FUNDI:
• Keith-Wegener classification of hypertensive retinopathy:
• Grade I: Narrowing, sclerosis, increased tortuosity of the
arterioles with increased reflectiveness (silver wiring)
• Grade II: Arterio-venous nipping due to thickened
retinal arteries passing over the retinal veins
• Grade III: Plus flame shaped haemorrhages and soft
exudates (cotton wool) due to small infarcts
• Grade IV: plus papilloedema (blurring of the margins of
the optic disc)
EVALUATION
• History
• age, sex, occupation, address.
• PMH
• Family history
•           -HT, Diabetes, Heart disease, sudden death.
• Diet history
• - salt
•       -  drugs.
• Height, weight
• Pulse, BP
• Peripheral pulses
• Neck veins, bruits, thyroid
• Heart
• Abdominal mass, bruits.
• Neurologic exam.
• Fundoscopy
• smoking
• alcohol
• obesity
• BMI > 27 
• ­    Blood pressure
• ­    Blood sugar
• ­    Serum cholesterol, triglycerides
• Left ventricular enlargement
• Albuminuria.
Investigations
• Urinalysis, urine microscopy
• E&U, Creatinine
• CXR
• Fasting blood sugar
• Fasting lipid profile
• ECG
• Echocardiography
• Renal USS
• Urinary metanephrines if phaechromocytoma is
suspected
BENEFITS OF LOWERING BP
• Stroke reduction- 40%
• MI reduction - 25%
• Heat failure - >50%
LIFE STYLE MODIFICATION
• Lose weight if overweight. This can be
accomplished with the DASH diet, which is
rich in fruits and vegetables and encourages
the use of fat-free or low-fat milk and milk
products.
• Limit alcohol intake to 14 units per week for
women and 21 units per week in men
LIFE STYLE MODIFICATION
• Increase aerobic activity (30-45 min most days
of the week).
• Reduce sodium intake to no more than 100
mmol/d (2.4 g sodium or 6 g sodium chloride).
• Maintain adequate intake of dietary
potassium (approximately 90 mmol/d).
• Stop smoking and reduce intake of dietary
saturated fat and cholesterol for overall
cardiovascular health.
TREATMENT
TREATMENT
NICE GUIDELINES FOR HTN MNGT
Age <55years Age > 55 years
Black of African or
Carrebean descent
STEP 1 A C OR D
STEP 2 A+C A+C
STEP 3 A+C+D A+C+D
STEP 4 Resistant hypertension Resistant hypertension
A+C+D A+C+D
+Diuretic or alpha blocker +Diuretic or alpha blocker
or beta blocker or beta blocker
• The rationale for step 1 is that young
caucasians are more likely to have high renin;
while elderly and black patients have lower
renin levels
HYPERTENSIVE CRISIS
• Hypertensive emergency is a BP of 220/140 or
greater with target organ damage (TOD).
• Hypertensive urgency is defined as a BP above
180/110 without TOD
• Hypertensive emergencies encompass a
spectrum of clinical presentations in which
uncontrolled BPs lead to progressive or
impending end-organ dysfunction
HYPERTENSIVE EMERGENCIES
• Acute end-organ damage in the setting of a
hypertensive emergency may include the following
• Neurologic - Hypertensive encephalopathy, cerebral
vascular accident/cerebral infarction. subarachnoid
hemorrhage, intracranial hemorrhage
• Cardiovascular - Myocardial ischemia/infarction,
acute left ventricular dysfunction, acute pulmonary
edema, aortic dissection
• Others - Acute renal failure/insufficiency,
retinopathy, eclampsia, microangiopathic hemolytic
anemia
HYPERTENSIVE URGENCY
• Severe hypertension in the organ transplant
patient
• Preoperative hypertension
• Hypertension associated with burns
• Severe, uncontrolled hypertension
ACCELERATED/MALIGNANT HYPERTENSION

• Malignant / accelerated HTN occurs when blood


pressure rises suddenly with DBP >120mmHg.
• Clinical lesions are best seen in the retina.
• In accelerated hypertension, there are other
features of HTN retinopathy, but no
papilloedema
• However, in Malignant HTN, there is presence of
papilloedema
ACCELERATED/MALIGNANT HYPERTENSION

• The characteristic histologic change is fibrinoid


necrosis of the vessel wall
• If untreated, it can lead to renal failure, heart
failure, aortic dissection, stroke and may lead
to death.
PAPILLOEDEMA IN MALIGNANT
HYPERTENSION
HYPERTENSIVE ENCEPHALOPATHY

• An uncommon but serious complication of


HTN
• Poor prognosis if left untreated
• Headache, confusion, blurring of vision,
transient focal neurological deficit
• Prompt response to anti-hypertensives
• It is a diagnosis of exclusion
PARENTERAL THERAPY FOR HYPERTENSIVE
CRISIS
• SODIUM NITROPRUSSIDE: Rapid onset of action; 0.25-
2mcg/kg/min
• IV LABETALOL: alpha and beta blocker;
0.5-2mcg/kg/min
• IV NICARDIPINE: dihydropyridine calcium channel
blocker; infusion at 5mg/kg/hr
• IV HYDRALAZINE: direct relaxation of the vascular
smooth muscle; unpredictable hypotensive effect
• PHENTOLAMINE: alpha blocker used for
phaeochromocytoma
Factos responsible for poor BP control

• Non-Compliance Coffee
• Obesity Antidepressant
• NSAID Inadequate doses***
• Renal insufficiency Fear of causing
• Salt intake danger to the
patient***
• Alcohol Faith healing***
• Tobacco Fake drugs
Management of Hypertension in Pregnancy

• Discontinue ACEi or ARBs


• First drug of choice: Methyl dopa
• Second line agents are Nifedipine and
Labetalol
THANK YOU

You might also like